Robert Andrew Berman - Net Worth and Insider Trading
Robert Andrew Berman Net Worth
The estimated net worth of Robert Andrew Berman is at least $746,713 dollars as of 2025-01-03. Robert Andrew Berman is the CEO of enVVeno Medical Corp and owns about 222,236 shares of enVVeno Medical Corp (NVNO) stock worth over $746,713. Robert Andrew Berman is also the COO, Gen. Counsel, Sec. of Acacia Research Corp and owns about 0 shares of Acacia Research Corp (ACTG) stock worth over $0. Details can be seen in Robert Andrew Berman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Andrew Berman has not made any transactions after 2024-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Andrew Berman
Robert Andrew Berman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Andrew Berman owns 3 companies in total, including enVVeno Medical Corp (NVNO) , Anixa Biosciences Inc (ANIX) , and Acacia Research Corp (ACTG) .
Click here to see the complete history of Robert Andrew Berman’s form 4 insider trades.
Insider Ownership Summary of Robert Andrew Berman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NVNO | enVVeno Medical Corp | 2024-12-19 | director & CEO |
| ANIX | Anixa Biosciences Inc | 2012-09-19 | President and CEO |
| ACTG | Acacia Research Corp | 2006-05-02 | Exec. V.P. & Gen. Counsel & Sec. |
Robert Andrew Berman Latest Holdings Summary
Robert Andrew Berman currently owns a total of 2 stocks. Among these stocks, Robert Andrew Berman owns 222,236 shares of enVVeno Medical Corp (NVNO) as of December 19, 2024, with a value of $746,713 and a weighting of 100%. Robert Andrew Berman also owns 0 shares of Acacia Research Corp (ACTG) as of May 2, 2006, with a value of $0 and a weighting of 0%.
Latest Holdings of Robert Andrew Berman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | 2024-12-19 | 222,236 | 3.36 | 746,713 |
| ACTG | Acacia Research Corp | 2006-05-02 | 0 | 4.32 | 0 |
Holding Weightings of Robert Andrew Berman
Robert Andrew Berman Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Andrew Berman has made a total of 5 transactions in enVVeno Medical Corp (NVNO) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in enVVeno Medical Corp is the acquisition of 12,000 shares on December 19, 2024, which cost Robert Andrew Berman around $30,600.
According to the SEC Form 4 filings, Robert Andrew Berman has made a total of 0 transactions in Acacia Research Corp (ACTG) over the past 5 years. The most-recent trade in Acacia Research Corp is the sale of 27,500 shares on May 2, 2006, which brought Robert Andrew Berman around $316,250.
Insider Trading History of Robert Andrew Berman
- 1
Robert Andrew Berman Trading Performance
GuruFocus tracks the stock performance after each of Robert Andrew Berman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Andrew Berman is -3.88%. GuruFocus also compares Robert Andrew Berman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Andrew Berman within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Andrew Berman's insider trading performs compared to the benchmark.
Performance of Robert Andrew Berman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.11 | | | | | |
| Relative Return to S&P 500(%) | 15.43 | | | | | |
Robert Andrew Berman Ownership Network
Robert Andrew Berman Owned Company Details
What does enVVeno Medical Corp do?
Who are the key executives at enVVeno Medical Corp?
Robert Andrew Berman is the director & CEO of enVVeno Medical Corp. Other key executives at enVVeno Medical Corp include Chief Technology Officer Hamed Alavi , See Remarks Marc H. Glickman , and 10 percent owner Biodyne Holding, S.a. .
enVVeno Medical Corp (NVNO) Insider Trades Summary
Over the past 18 months, Robert Andrew Berman made 1 insider transaction in enVVeno Medical Corp (NVNO) with a net purchase of 12,000. Other recent insider transactions involving enVVeno Medical Corp (NVNO) include a net purchase of 81,433 shares made by Francis Duhay , a net purchase of 9,620 shares made by Matthew Jenusaitis , and a net sale of 8,334 shares made by Hamed Alavi .
In summary, during the past 3 months, insiders sold 0 shares of enVVeno Medical Corp (NVNO) in total and bought 111,953 shares, with a net purchase of 111,953 shares. During the past 18 months, 8,334 shares of enVVeno Medical Corp (NVNO) were sold and 111,953 shares were bought by its insiders, resulting in a net purchase of 103,619 shares.
enVVeno Medical Corp (NVNO)'s detailed insider trading history can be found in Insider Trading Tracker table.
enVVeno Medical Corp Insider Transactions
Robert Andrew Berman Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Andrew Berman. You might contact Robert Andrew Berman via mailing address: C/o Itus Corporation, 12100 Wilshire Boulevard, Suite 1275, Los Angeles Ca 90025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
